Treatment of children with familial hypercholesterolaemia.
D000293:Adolescent; D002446:Celiac Disease / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use; D005260:Female; D005494:Folic Acid Deficiency / Q000139:chemically induced; D005500:Follow-Up Studies; D006579:Heterozygote; D006801:Humans; D006937:Hypercholesterolemia / Q000178:diet therapy / Q000188:drug therapy / Q000235:genetics*; D007223:Infant; D008297:Male; D010758:Phosphorus / Q000097:blood; D014801:Vitamin A / Q000097:blood; D014810:Vitamin E / Q000097:blood
D005231:Fatty Acids, Unsaturated; D002792:Cholestyramine Resin; D014801:Vitamin A; D014810:Vitamin E; D010758:Phosphorus; D002994:Clofibrate